Journals / Bozok Tıp Dergisi / 2014 / Cilt: 4 - Sayı: 3

Association of Insulin Resistance with Microalbuminuria in Non-Diabetic Subjects

DİYABETİK OLMAYAN BİREYLERDE İNSÜLİN DİRENCİ MİKROALBÜMİNÜRİ İLİŞKİSİ

Pages
34–40
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Nondiabetic subjects, with these findings, will increase therisk of cardiovascular mortality and should be followed up closely.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Insulin resistance and microalbuminuria are being more pronounced risk factors forcardiovascular diseases in patients with type 2 diabetes.
📊
Key Findings & Data:Materials and Methods: Fourty-nine patients, who have been admitted to the hospital andexamined in terms ofinsulin resistance, microalbuminuria levels, waist-hip ratio (WHR), body massindex (BMI), fat percentage and routine biochemical parameters were recorded.
💡
Conclusion & Impact:Nondiabetic subjects, with these findings, will increase therisk of cardiovascular mortality and should be followed up closely.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Insulin resistance and microalbuminuria are being more pronounced risk factors forcardiovascular diseases in patients with type 2 diabetes. We aimed to investigate the relationshipbetween these parameters in non-diabetic patients. Materials and Methods: Fourty-nine patients, who have been admitted to the hospital andexamined in terms ofinsulin resistance, microalbuminuria levels, waist-hip ratio (WHR), body massindex (BMI), fat percentage and routine biochemical parameters were recorded. Results: Microalbuminuria levels, BMI, fat percentages and hs-CRP levels of the patients withinsulin resistance were higher than those without insulin resistance.There was no difference interms of WHR, fasting blood glucose, and lipid levels. Conclusion: There is an increased cardiovascular risk in the presence of insulin resistance andmicroalbuminuria in diabetic patients. Nondiabetic subjects, with these findings, will increase therisk of cardiovascular mortality and should be followed up closely.

Özet

Amaç: İnsülin direnci ve mikroalbüminüri, tip 2 diyabetli hastalarda daha belirgin olmak üzere,kardiyovasküler hastalıklar için risk faktörüdür. Biz bu parametreleri diyabetik olmayan bireylerdearaştırmayı amaçladık. Gereç ve yöntemler: Çalışmamız hastanemiz iç hastalıkları polikliniğine başvuran 49 hastanındosya verileri incelenerek insülin direnci, mikroalbüminüri düzeyi, bel kalça oranı (BKO), bedenkitle indeksi (BKİ), yağ yüzdesi ve rutin biyokimyasal parametreleri kaydedildi. Bulgular: İnsülin direnci olan hastaların mikroalbüminüri düzeyleri, BKİ, yağ yüzdeleri ve yüksekduyarlıklı C-reaktif protein (hs-CRP) düzeyleri, insülin direnci olmayanlara göre yüksekti. BKO, açlıkkan şekeri, ve lipid değerleri açısından ise fark yoktu. Mikroalbüminüri düzeyi ile insülin direnci,BKİ ve yağ yüzdesi düzeyleri arasında pozitif korelasyon vardı.Sonuç: Diyabetik hastalarda, insülin direnci ve mikroalbüminüri varlığında kardiyovasküler riskartmıştır. Bu bulguların diyabetik olmayan hastalarda da bulunması kardiyovasküler mortalite riskini arttıracağından daha yakın takip edilmesi gerekir.

🔖

Cite This Article

YÜKSEL, Ş., AHSEN, A., ULU, M. S., ACA, A., ELBİR, A. (2022). Association of Insulin Resistance with Microalbuminuria in Non-Diabetic Subjects. Bozok Tıp Dergisi, Cilt: 4 - Sayı: 3, 34–40. https://ajindex.com/articles/468939

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Sheu WH, Jeng CY, Young MS, Le WJ, Chen YT. Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes. Am J Med Sci. 2000;319(2):84-8
  2. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334(15):952-7
  3. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. 2005;307(5708):384 -7
  4. Prentki M, Joly E, El-Assaad W, Roduit R. Malonyl-CoA signalling, lipid partitioning, and glucolipotoxicity: role in β-cell adaptation and failure in the etiology of diabetes. Diabetes. 2002;51(3):405–13
  5. The Expert Committee on the diagnosis and classification of Diabetes Mellitus: Report of the Expert committee on the diagnosis and classification of Diabetes Mellitus. Diabetes Care. 1997;20(7):1183-97
  6. Parving H-H, Mauer M, Ritz E. Diabetic nephropathy. In The Kidney. 7th ed. Brenner BM, Ed. Philadelphia: WB Saunders, 2004. p. 1777–818
  7. Mattock MB, Morrish NJ, Viberti G,Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes. 1992;41(6):736- 41
  8. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 1990;300(6720): 297-300
  9. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet. 1988;2(8610):530-3
  10. Groop L, Ekstrand A, Forsblom C, Widén E, Groop PH, Teppo AM, et al. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin- dependent) diabetes mellitus. Diabetologia. 1993;36(7): 642-7
  11. Nosadini R, Cipollina MR, Solini A,Sambataro M, Morocutti A, Doria A,et al. Close relationship between microalbuminuria and insulin resistance in essential hypertension and non-insulin dependent diabetes mellitus. J Am Soc Nephrol. 1992;3(4):56-63
  12. Haffner SM, Stern MP, Gruber MK, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria. Potential marker for increased cardiovascular risk factors in non-diabetisubjects? Arteriosclerosis. 1990;10(5):727-31
  13. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE. Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburg Epidemiology of Diabetes Complications Study. Kidney